MRVI Maravai LifeSciences Holdings, Inc.: Net earnings per share growth forecast for next year

Public company logo of Maravai LifeSciences (MRVI)

The Maravai LifeSciences (MRVI) B2B ecosystem retains clients through strict FDA compliance. Growth is based on the unique CleanCap technology for mRNA synthesis, while reliability is guaranteed by streamlined cold-chain logistics for reagents. The projected earnings per share growth benchmark visualizes market expectations, where -6.30 shows the current value of the metric, confirming the business's financial stability within the medical diagnostics sector.

MRVI: Maravai LifeSciences Corp Earnings growth forecast for next year 07/04/2022 - 11/17/2026

Analytical breakdowns and data insights for company Maravai LifeSciences Corp (MRVI)

- price and consensus price forecast:
Summary company analysis:Maravai, MRVI
Finished products of Maravai LifeSciences Holdings

To assess the credit quality of Maravai LifeSciences (MRVI), the analyst utilizes an EPS growth forecasting model for the coming year, which consolidates daily market expectations for profit dynamics to identify capital drawdown risks. The stability of this metric is supported by the company's exceptional pricing power in the mRNA components segment and its ownership of the CleanCap technology, which creates inelastic demand from the biotechnology sector.

Main competitors

A (agilent.com) - Earnings growth forecast for next year|DGX - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year ILMN|EXAS - Expected net earnings per share growth next year|Earnings growth forecast for next year RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Expected net earnings per share growth next year|Anbio Biotechnology - Earnings growth forecast for next year|Expected net earnings per share growth next year soterahealth.com|QDEL: Earnings growth forecast for next year|OPKO Health - Expected earnings per share trend next year|CDNA (CareDx, Inc) - Earnings growth forecast for next year|Expected net earnings per share growth next year Fulgent FLGT|Net earnings per share growth forecast for next year Standard BioTools Inc. (LAB)|CTKB (Cytek Biosciences, Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year OSUR (OraSure Corp)|Consensus forecast of earnings per share growth for next year Exagen Inc. (XGN)|MDXH: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Lucid Diagnostics Inc LUCD|PRE (Prenetics Global Ltd) - Expected earnings per share growth for next year|Expected earnings per share growth for next year Insight Molecular|TRIB (Trinity Biotech) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year PRPH|Earnings growth forecast for next year AIMD|Projected earnings per share increase next year CODX|Net earnings per share growth forecast for next year Heart Test Laboratories HSCS|BMRA: Projected earnings per share growth rate for next year|CDIO - Net earnings per share growth forecast for next year|Onconetix Corp (ONCO) - Expected earnings per share growth for next year|VRAX (Virax Biolabs Group Ltd) - Expected earnings per share growth for next year|Expected net earnings per share growth next year Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Earnings growth forecast for next year|AXDX - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year centogene.com (CNTG)|Consensus forecast of earnings per share growth for next year Enzo Biochem|Consensus forecast of earnings per share growth for next year FRES|Net earnings per one share growth forecast for next year GTG Labs|23andMe Holding Co - Earnings growth forecast for next year|PMD - Earnings growth forecast for next year